Method Development and Validation of Montelukast in Bulk and Pharmaceutical Dosage form by RP-HPLC

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2012, Vol 1, Issue 2

Abstract

The present work describes a simple, precise and accurate HPLC method for estimation of montelukast sodium in bulk and in tablet dosage form. Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene (CysLT1) receptor. The separation was achieved by using Waters symmetry shield RP-C8 column and acetonitrile: sodium di-hydrogen Phosphate dehydrate (pH 3.7) in proportion of 70:30 v/v as mobile phase, at a flow rate of 1.5 ml/min. Detection was carried out at 225 nm. The retention time of montelukast sodium was found to be 3.721 min. The limit of detection was found 0.1357 µg/ml and limit of quantification 0.4111 µg/ml. The accuracy and reliability of the proposed method was ascertained by evaluating various validation parameters like linearity (1-30 µg/ml), accuracy, precision, robustness and specificity according to ICH guidelines. The method was statistically validated and RSD was found to be less than 2% indicating high degree of accuracy and precision of the proposed HPLC method. Due to its simplicity, rapidness, high precision and accuracy, the proposed HPLC method may be used for determining Montelukast in bulk or in pharmaceutical dosage forms.

Authors and Affiliations

Minaketan Sahoo*| Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India-754202, B V V Ravi Kumar| Roland institute of pharmaceutical sciences, Berhampur, Ganjam,Odisha, N K Tripathy| Dept. of zoology, Berhampur University, Berhampur, Ganjam, Odisha, India, Saroj Kumar Patro| Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India-754202

Keywords

Related Articles

In Vitro Cytotoxicity Assessment of Imiquimod Loaded Liposomal Gel Formulation Using Basal Cell Carcinoma Cell Line: Part-II

This study was undertaken to address the efficacy of newly formed Imiquimod loaded liposomal gel formulation. The study evaluated the acute toxic effect of liposomal gel formulation intended to be used in skin cancers li...

CURRENT NECESSITY OF PROTEASES: OVERVIEW

The use of proteases as medicine is also popular as the study of proteases has helped us better understands inflammatory conditions and immune regulation. If a protein (part of living cell) component including other nece...

RAPID DETECTION OF HLA-B27 SEQUENCE SPECIFIC ALLELES BY IN-HOUSE OPTIMIZED MOLECULAR ASSAY FOR THE DETECTION OF ANKYLOSING SPONDYLITIS

Introduction: Ankylosing Spondylitis (AS) is a long term disease, involved in inflammation of the joints between the spinal bones and the joints between the spine and pelvis. Chronic inflammation in these areas causes p...

ECOPHARMACOVIGILANCE: ITS IMPORTANCE AND CHALLENGES

Active pharmaceutical ingredients represent a group of emerging environmental contamination. Even in trace amounts, they are of great concern due to then continuous introduction into the environment, their impact an ecos...

CHEMICAL CONSTITUENTS AND BIOLOGICAL ACTIVITY OF FICUS PLATYPODA (MIQ.) LEAVES

Six compounds were isolated for the first time from the leaves of Ficus platypoda and were identified as 3- methoxycarpachromene [1], pheophorbide-a methyl ester [2], pheophorbide-b methyl ester [3], (6S, 9R)-3-oxo-6-...

Download PDF file
  • EP ID EP1515
  • DOI -
  • Views 569
  • Downloads 30

How To Cite

Minaketan Sahoo*, B V V Ravi Kumar, N K Tripathy, Saroj Kumar Patro (2012). Method Development and Validation of Montelukast in Bulk and Pharmaceutical Dosage form by RP-HPLC. Journal of Biomedical and Pharmaceutical Research, 1(2), 18-26. https://europub.co.uk/articles/-A-1515